Revolutionizing TB Diagnosis with Rapid, Accurate Detection and AMR Profiling
Empowering Healthcare to Save Lives Worldwide
EMPE Diagnostics AB
Founded in 2015, EMPE Diagnostics AB is a pioneering healthcare company based on innovations from the prestigious Karolinska Institutet in Sweden. We are dedicated to addressing the global tuberculosis (TB) crisis by developing rapid, reliable, and cost-effective diagnostic solutions. Our mission is to combat TB and antimicrobial resistance (AMR) by providing tests that not only detect TB infections but also simultaneously profile antibiotic resistance, ensuring patients receive the correct treatment from the outset.
With a focus on India, where over 2.7 million new TB infections occur annually, EMPE Diagnostics is playing a pivotal role in the fight against TB. Our innovative products have gained full regulatory approval, and we are fully equipped to support global demand through our manufacturing facility in Hyderabad, India. We are proud to be ISO 13485 certified and to meet the "Made in India" criteria, which is crucial for government contracts.
Our Expertise
At the forefront of medical innovation, we specialize in developing cutting-edge solutions for rapid and accurate Tuberculosis (TB) diagnosis and antimicrobial resistance (AMR) profiling. Our advanced molecular diagnostics leverage state-of-the-art technology to deliver precise results in record time, enabling healthcare professionals to make critical treatment decisions with confidence. With a deep understanding of TB biology, global health challenges, and diagnostic needs, we are committed to transforming TB care by enhancing early detection and personalized treatment plans, driving better patient outcomes, and combating the growing threat of drug-resistant TB.
Our Supporters
EMPE Diagnostics has been fortunate to receive backing from leading global organizations and investors who believe in our mission to eradicate tuberculosis. Our company has received grants from the European Innovation Council (EIC) and the Bill & Melinda Gates Foundation, making us the first company to secure funds from both esteemed organizations.